Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Gipper who wrote (3753)	6/30/1998 11:23:00 AM
From: Mama Bear	Read Replies (1) \| Respond to of 5736

"I prefer fighting to running. " And with that statement you show that you do not understand the objective of investing in the stock market, as I explained in my previous post. Barb

To: Gipper who wrote (3753)	6/30/1998 11:24:00 AM
From: RealMuLan	Read Replies (1) \| Respond to of 5736

FWIW: CCSI and other companies, which are currently slated for review by the website, are under consideration as subjects for research by MDC Inc. Company Press Release Tuesday June 30, 9:30 am Eastern Time SOURCE: MDC Inc. Breaking News and Research to be Made Available By Leader in Internet Financial Information. LAS VEGAS, June 30 /PRNewswire/ -- Breaking news and in depth research on select companies will soon be available through www.mdcinc.com, a leader in the distribution of internet financial information. By simply visiting www.mdcinc.com and completing the brief, free registration form, visitors will gain access to the most comprehensive and educational financial website on the Internet in addition to the future publication of research on a variety of different companies. Companies such as Alpnet (Nasdaq: AILP - news), Biocontrol (Nasdaq: BICO - news), Chromatics Col. (Nasdaq: CCSI - news), Compositech LTD (Nasdaq: CTEK - news) and Comput Concepts (Nasdaq: CCEE - news) are currently slated for review by the website and are under consideration as subjects for research. Just take the first step and click through to www.mdcinc.com. SOURCE: MDC Inc.